T80.A11D Non-ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter

Name of the Condition

• Non-ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter.

Summary

This condition describes a delayed hemolytic transfusion reaction resulting from non-ABO blood group incompatibility, occurring during a subsequent encounter. It arises when the recipient’s immune system reacts to non-ABO antigens in transfused blood or blood products, leading to hemolysis days to weeks after the transfusion. The "subsequent encounter" designation indicates the patient is being seen for this reaction after the initial episode.

Causes

Delayed hemolytic transfusion reactions due to non-ABO incompatibility are caused by immune responses to minor blood group antigens (e.g., Rh, Kell, Duffy, or Kidd systems) or antibodies against platelet or plasma proteins. These reactions typically result from prior sensitization through pregnancy, previous transfusions, or organ transplants, where the recipient has developed antibodies against these antigens. The reaction is triggered when incompatible blood is transfused, leading to delayed immune-mediated destruction of red blood cells.

Risk Factors

• Prior exposure to non-ABO antigens (e.g., through pregnancy or previous transfusions)
• History of multiple transfusions
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine
• Fatigue or malaise
• Unexplained anemia
• Elevated bilirubin levels

Diagnosis

Diagnosis involves clinical evaluation of symptoms occurring days to weeks after transfusion, combined with laboratory tests. Key findings include a positive direct antiglobulin test (DAT), evidence of hemolysis (e.g., elevated lactate dehydrogenase, decreased haptoglobin), and identification of non-ABO antibodies in the recipient’s serum. Transfusion history and antibody screening are critical for confirming the cause.

Treatment Options

Management focuses on supportive care, including monitoring for hemolysis and anemia. Transfusion of compatible blood products may be necessary if anemia is severe. Corticosteroids or other immunosuppressants are rarely used but may be considered in severe cases. Addressing the underlying cause, such as discontinuing incompatible transfusions, is essential.

Prognosis and Follow-Up

Prognosis is generally favorable with appropriate management, though complications like renal impairment or severe anemia can occur. Follow-up includes monitoring hemoglobin levels, bilirubin, and antibody status to ensure resolution. Patients with a history of delayed reactions may require extended observation or specialized transfusion protocols.

Complications

• Acute kidney injury due to hemoglobinuria
• Severe anemia requiring transfusion
• Prolonged jaundice
• Rarely, disseminated intravascular coagulation (DIC)

Lifestyle & Prevention

Prevention involves thorough pre-transfusion antibody screening and crossmatching to identify non-ABO incompatibilities. Patients with a history of reactions should receive antigen-negative blood products. Educating healthcare providers on the risks of delayed reactions and the importance of accurate transfusion records can reduce future occurrences.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, jaundice, dark urine, or unexplained fatigue develop after a transfusion, especially if they occur days to weeks later. Prompt evaluation is necessary to confirm the reaction and prevent complications.

Tips for Medical Coders

Document the timing of the reaction (delayed) and the encounter type (subsequent) to support accurate coding. Ensure clinical notes specify non-ABO incompatibility and confirm the reaction occurred after a transfusion. Include details of antibody testing or hemolysis evidence to validate the diagnosis.